Immune-Mediated Disorders Causing Bleeding or Thrombosis in Lymphoproliferative Diseases

被引:12
|
作者
Lechner, Klaus [1 ]
Pabinger, Ingrid [1 ]
Obermeier, Hanna Lena [1 ]
Knoebl, Paul [1 ]
机构
[1] Med Univ Vienna, Dept Med 1, Clin Div Haematol & Haemostaseol, A-1090 Vienna, Austria
来源
SEMINARS IN THROMBOSIS AND HEMOSTASIS | 2014年 / 40卷 / 03期
关键词
autoimmune complications; lymphoma; treatment; thrombosis; bleeding; VON-WILLEBRAND-SYNDROME; CHRONIC LYMPHOCYTIC-LEUKEMIA; ACQUIRED GLANZMANNS-THROMBASTHENIA; FACTOR-VIII INHIBITOR; NON-HODGKINS-LYMPHOMA; FACTOR-X DEFICIENCY; LIGHT-CHAIN AMYLOIDOSIS; MARGINAL-ZONE LYMPHOMA; AUTOIMMUNE HEMOLYTIC-ANEMIA; STEM-CELL TRANSPLANTATION;
D O I
10.1055/s-0034-1371004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Bleeding and thrombosis are important complications in patients with malignant lymphomas. They may be due to direct actions of the lymphoma, such as venous compression or bone marrow infiltration, but they may also be caused by paraneoplastic phenomena, which are immune-mediated in most of the cases. The most important paraneoplastic immune-mediated disorders in lymphomas causing bleeding are autoimmune thrombocytopenia, acquired hemophilia A and acquired von Willebrand syndrome. In addition, there are a variety of other less common immune-mediated bleeding conditions, such as acquired thrombasthenia, acquired factor X-, V-, XI-, XII-, or prothrombin deficiency. The presence of antiphospholipid antibodies is a rare condition predisposing to venous and arterial thrombosis and there are other very uncommon conditions, which predispose exclusively to arterial thrombosis such as hyperlipidemic xanthomatosis. Interestingly, there is hardly any correlation between the histological type and the aggressiveness of lymphoma and the type and prevalence of the immune-mediated conditions. Successful treatment of the underlying lymphoma is often associated with definite and sustained resolution of the immune-mediated disorder.
引用
收藏
页码:359 / 370
页数:12
相关论文
共 50 条
  • [1] Acquired immune-mediated thrombophilia in lymphoproliferative disorders
    Lechner, Klaus
    Simonitsch, Ingrid
    Haselboeck, Johanna
    Jaeger, Ulrich
    Pabinger, Ingrid
    LEUKEMIA & LYMPHOMA, 2011, 52 (10) : 1836 - 1843
  • [2] Spectrum of Movement disorders in pediatric immune-mediated diseases
    Saan, A.
    Linn, K.
    MinAye, A.
    Hlaing, C.
    Ko, K.
    WintAung, H.
    Lin, N.
    WintAung, Y.
    MOVEMENT DISORDERS, 2019, 34 : S615 - S616
  • [3] Immune-Mediated Lung Diseases
    Jacobs, Kathleen
    Kligerman, Seth
    SEMINARS IN ULTRASOUND CT AND MRI, 2019, 40 (03) : 213 - 228
  • [4] IMMUNOTHERAPY OF IMMUNE-MEDIATED DISEASES
    PANAYI, GS
    KINGSLEY, GH
    LANCHBURY, JSS
    QUARTERLY JOURNAL OF MEDICINE, 1992, 83 (303): : 489 - 495
  • [5] IMMUNE-MEDIATED SKIN DISEASES
    ROSSER, EJ
    VETERINARY QUARTERLY, 1995, 17 : S37 - S38
  • [6] IMMUNE-MEDIATED DISEASES OF THE BLOOD
    DODDS, WJ
    ADVANCES IN VETERINARY SCIENCE AND COMPARATIVE MEDICINE, 1983, 27 : 163 - 196
  • [7] Osteopontin in Immune-mediated Diseases
    Rittling, S. R.
    Singh, R.
    JOURNAL OF DENTAL RESEARCH, 2015, 94 (12) : 1638 - 1645
  • [8] Immune-Mediated Neurological Disorders
    Teerin Liewluck
    Augusto Miravalle
    Current Neurology and Neuroscience Reports, 2015, 15
  • [9] Treating immune-mediated diseases
    Léger, JM
    PRESSE MEDICALE, 2006, 35 (04): : 707 - 708
  • [10] IMMUNE-MEDIATED DISORDERS OF CATS
    WERNER, LL
    GORMAN, NT
    VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE, 1984, 14 (05) : 1039 - 1064